Journal Watch: The DEPICT-1 52-Week Study

The DEPICT-1 Study evaluated the efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes.

Journal Watch: APCam11, PROLOG and ASCEND

January/February 2019: In this edition, Journal Watch highlights the APCam11 and PROLOG trials in individuals with Type 1 diabetes.

Journal Watch: Continuous Glucose Monitoring and Risk of Hypoglycemia

May/June 2018: These papers summarize the recent progress in continuous glucose monitoring (CGM) measurements and interpretation, describe available CGM systems, address practical issues related to daily use and discuss proposed measures of glycemic control other than A1C.

Journal Watch: Diabetic Neuropathy Treatments

November/December 2017: In this series of studies on diabetic neuropathy treatments, the first yielded promising data, but the subsequent Phase 2 studies did not show any benefit, leading to cessation of the drug development program.